Ifenec (Econazole Nitrate)

Econazole nitrate, the active ingredient in Ifenec, blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for ergosterol synthesis. By disrupting ergosterol production, the drug compromises the integrity of the fungal cell membrane, inhibiting growth and leading to the death of susceptible dermatophytes and yeasts.

The dosage of Ifenec is determined by the prescribing healthcare professional based on the type and severity of the infection, the patient’s age, and the area of skin involved. Patients should follow the specific instructions provided by their prescriber and the product label.

Safety data for econazole nitrate in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any potential risk to the fetus or infant. Pregnant or nursing individuals should discuss use with their healthcare provider before starting treatment.

To order Ifenec, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Ifenec (econazole nitrate) belongs to the imidazole class, offering broad‑spectrum activity against dermatophytes and yeasts. Compared with allylamine agents such as terbinafine, econazole may have a slightly slower onset but is effective for a wide range of superficial infections. Choice of therapy depends on infection type, patient tolerance and local resistance patterns.

Ifenec should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, direct sunlight and extreme heat. Do not freeze the preparation, and ensure the container is tightly closed when not in use.

Ifenec is applied topically to the affected skin area. The prescribed amount is spread thinly over the lesion and a small margin of surrounding healthy skin, usually twice daily or as directed by a healthcare professional. Hands should be washed before and after application, and the treated area should be allowed to dry.

Serious adverse reactions are rare but may include severe allergic responses such as swelling, hives, difficulty breathing, or contact dermatitis with intense rash or blistering. If any of these symptoms occur, discontinue use immediately and seek medical attention.

Individuals with a known hypersensitivity to econazole nitrate, other imidazole antifungals, or any component of the formulation should avoid using Ifenec. It should also be avoided on extensive broken skin, deep wounds, or in patients where a systemic antifungal is required without medical supervision.